We are live on ! Find out more
TXG icon

10x Genomics

268 hedge funds and large institutions have $2.36B invested in 10x Genomics in 2024 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 104 increasing their positions, 73 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

209% more call options, than puts

Call options by funds: $6.36M | Put options by funds: $2.06M

42% more repeat investments, than reductions

Existing positions increased: 104 | Existing positions reduced: 73

20% more first-time investments, than exits

New positions opened: 59 | Existing positions closed: 49

3% more funds holding

Funds holding: 261 → 268 (+7)

2% less capital inflows, than outflows

Capital inflows: $311M | Capital outflows: $318M

1.65% less ownership

Funds ownership: 99.74% → 98.09% (-1.7%)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
268
Holders Change
+7
Holders Change %
+2.68%
% of All Funds
3.83%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
59
Increased
104
Reduced
73
Closed
49
Calls
$6.36M
Puts
$2.06M
Net Calls
+$4.3M
Net Calls Change
+$2.66M

TXG Hedge Fund Activity: Q3 2024 in Review

268 of the 6,990 institutional investors tracked by Wall St. Rank reported a position in 10x Genomics (TXG) for Q3 2024, worth a combined $2.36B — up 15% from $2.05B a quarter earlier.

Buyers outnumbered sellers: 59 funds opened new TXG positions and 49 closed out — a net gain of 10 holders — while 104 added to existing stakes and 73 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $50.6M. The largest seller was Generation Investment Management, exiting entirely with an estimated $56.1M sold.

  • 268 institutional investors held 10x Genomics (TXG) as of Q3 2024, up from 261 in Q2 2024.
  • Funds reported $2.36B of 10x Genomics stock for Q3 2024, up 15% quarter-over-quarter.
  • 59 funds opened new 10x Genomics positions in Q3 2024 and 49 closed out, a net change of +10 holders.
  • The largest 10x Genomics buyer in Q3 2024 was Citadel Advisors, an estimated $50.6M added.
  • The largest 10x Genomics seller in Q3 2024 was Generation Investment Management, an estimated $56.1M sold.

Based on aggregated 13F filings for Q3 2024.